SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Trends of coinfections among healthy blood donors: COVID-19 pandemic repercussion
7 references·0 citing·32 second hop
Trends of coinfections among healthy blood donors: COVID-19 pandemic repercussion (2024)Trends of coinfections among healthy bloo…Exploring the unseen effect of COVID 19 pandemic on blood transfusion services in a tertiary care centre (2022)Exploring the unseen effect o…Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India (2021)Deterrents in recruitment of …Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria. (2015)Seroprevalence of transfusion…Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi (2013)Transfusion transmittable inf…Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century (2012)Emerging infectious agents an…Emerging infectious disease agents and their potential threat to transfusion safety (2009)Emerging infectious disease a…Blood transfusion services: organization is integral to safety. (2001)Blood transfusion services: o…Antibody to Hepatitis B Core Antigen as a Paradoxical Marker for Non-A, Non-B Hepatitis Agents in Donated Blood (1986)Transmission of Human Immunodeficiency Virus (HIV) by Blood Transfusions Screened as Negative for HIV Antibody (1988)Plasma is a strategic resource (2016)Civilian walking blood bank emergency preparedness plan (2021)Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases (2023)Prevalence of hepatitis B virus and hepatitis C virus among blood donors at a tertiary care hospital in India: a five‐year study (2010)Nucleic A cid T echnology ( NAT ) testing for blood screening: impact of individual donation and M ini P ool – NAT testing on analytical sensitivity, screening sensitivity and clinical sensitivity (2014)Burden of transfusion transmissible viral infections among blood donors at a tertiary care referral teaching hospital in South India (2016)Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland (2016)Seroprevalence and incidence of transfusion‐transmitted infectious diseases among blood donors from regional blood transfusion centres in Burkina Faso, West Africa (2011)Transfusion transmitted infections – A retrospective analysis from the National Blood Transfusion Service in Eritrea (2011)The infectious risks in blood transfusion as of today – A no black and white situation (2016)Seroprevalence and Trends of Transfusion Transmissible Infections in Blood Donors in Andaman and Nicobar Islands- An Institutional Retrospective Study (2017)Safe blood supply in sub-Saharan Africa: challenges and opportunities (2021)Perception of Risk (1987)Risk of human immunodeficiency virus (HIV) transmission by blood transfusions before the implementation of HIV‐1 antibody screening (1991)Science and the Precautionary Principle (2000)Transfusion‐associated infections: 50 years of relentless challenges and remarkable progress (2010)Donor Testing and Risk: Current Prevalence, Incidence, and Residual Risk of Transfusion-Transmissible Agents in US Allogeneic Donations (2011)Prevention of transfusion-transmitted infections (2019)Volunteers' motivations: A functional strategy for the recruitment, placement, and retention of volunteers (1992)Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection (2010)Guidance for the procurement of COVID‐19 convalescent plasma: differences between high‐ and low‐middle‐income countries (2020)Factors influencing plasma donation behavior of COVID‐19 recovered patients in Bangladesh: A pilot study (2022)Effects of the COVID-19 pandemic on supply and use of blood for transfusion (2020)Impact of COVID‐19 on blood centres in Zhejiang province China (2020)Prepare to adapt: blood supply and transfusion support during the first 2 weeks of the 2019 novel coronavirus ( COVID ‐19) pandemic affecting Washington State (2020)Impact of COVID-19 Pandemic on Seroprevalence of HIV, HBV, HCV and HTLV I-II in a Blood Bank in Medellín, Colombia, 2019–2022 (2023)Blood donor characteristics and blood safety before and during the COVID ‐19 pandemic: A BEST Collaborative international survey (2025)Trend of blood donation including coronavirus pandemic: A nationwide cross-sectional study during 2017–2022 in Iran (2025)Prevalence of p24 antigen among a cohort of HIV antibody negative blood donors in Sokoto, North Western Nigeria - the question of safety of blood transfusion in Nigeria (2014)Revolutionizing blood bank inventory management using the TOC thinking process: An Indian case study (2017)
this work references cited by second hop

References

  • 2009Emerging infectious disease agents and their potential threat to transfusion safety430 cited
  • 2012Emerging infectious agents and the nation's blood supply: responding to potential threats in the 21st century70 cited
  • 2015Seroprevalence of transfusion transmissible infections (TTI), in first time blood donors in Abeokuta, Nigeria.43 cited
  • 2013Transfusion transmittable infections - Seroprevalence among blood donors in a tertiary care hospital of Delhi22 cited
  • 2001Blood transfusion services: organization is integral to safety.15 cited
  • 2022Exploring the unseen effect of COVID 19 pandemic on blood transfusion services in a tertiary care centre14 cited
  • 2021Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India12 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work